------ Forwarded Message
From: "NIH OLIB (NIH/OD)" <[log in to unmask]>
Reply-To: "NIH OLIB (NIH/OD)" <[log in to unmask]>
Date: Thu, 25 Jan 2007 14:27:07 -0500
To: <[log in to unmask]>
Conversation: NIDA LAUNCHES CENTERS OF EXCELLENCE FOR DRUG ABUSE INFORMATION
Subject: NIDA LAUNCHES CENTERS OF EXCELLENCE FOR DRUG ABUSE INFORMATION
U.S. Department of Health and Human Services
NATIONAL INSTITUTES OF HEALTH
NIH News
National Institute on Drug Abuse (NIDA)
<http://www.nida.nih.gov/>
FOR IMMEDIATE RELEASE: Thursday, January 25, 2007
CONTACT: Dorie Hightower or Sara Rosario Wilson, 301-443-6245,
<e-mail: [log in to unmask]>, Contacto en Espaņol:, 301-594-6145
NIDA LAUNCHES CENTERS OF EXCELLENCE FOR DRUG ABUSE INFORMATION
The National Institute on Drug Abuse (NIDA), part of the National Institutes
of Health (NIH), today announced the establishment of four Centers of
Excellence for Physician Information -- these Centers will serve as national
models to support the advancement of addiction awareness, prevention, and
treatment in primary care practices. The NIDA Centers of Excellence (NIDA
COEs) will target physicians-in-training, including medical students and
resident physicians in primary care specialties (e.g., internal medicine,
family practice, and pediatrics).
The NIDA COEs are being developed in collaboration with the American Medical
Association's (AMA) Research Consortium and are part of NIDA's ongoing
Physician Outreach Program. The NIDA COEs will identify drug addiction
knowledge gaps, develop educational materials and resources specifically
designed for physicians in training to address those gaps, and determine the
most effective means of delivering this information. As a result, the COEs
seek to raise the awareness among primary care physicians of drug addiction
as a health issue and to further facilitate the dissemination of knowledge
on how best to prevent, diagnose, and treat patients struggling with
prescription and illicit drug abuse.
"These new Centers of Excellence are just one step in a broad cooperative
effort to increase awareness among primary care physicians and other health
professionals, as well as patients, about drug addiction as a major public
health issue," said NIH Director Dr. Elias A. Zerhouni.
NIDA is establishing the Centers at academic medical institutions across the
country. The NIDA COEs for 2007 will be located at Creighton University
School of Medicine, Omaha, Nebraska; the University of Pennsylvania School
of Medicine in collaboration with Drexel University College of Medicine; the
University of North Dakota School of Medicine and Health Sciences; and the
Massachusetts Consortium of Medical Schools, including the University of
Massachusetts Medical School, Tufts University School of Medicine, Boston
University School of Medicine, and Harvard Medical School/Cambridge Health
Alliance. The NIDA COEs will focus on a variety of areas, including
prescription drug abuse, methamphetamine abuse and addiction, co morbid
substance abuse and mental illness, and other issues related to drug abuse.
"This AMA-NIDA collaboration is part of NIDA's ongoing activities to provide
physicians and other medical professionals with the tools and skills needed
to incorporate NIDA-funded research findings into their clinical practice,"
said NIDA Director Dr. Nora D. Volkow.
The National Institute on Drug Abuse is a component of the National
Institutes of Health, U.S. Department of Health and Human Services. NIDA
supports most of the world's research on the health aspects of drug abuse
and addiction. The Institute carries out a large variety of programs to
ensure the rapid dissemination of research information and its
implementation in policy and practice. Fact sheets on the health effects of
drugs of abuse and information on NIDA research and other activities can be
found on the NIDA home page at <http://www.drugabuse.gov>.
The National Institutes of Health (NIH) -- The Nation's Medical Research
Agency -- includes 27 Institutes and Centers and is a component of the U.S.
Department of Health and Human Services. It is the primary federal agency
for conducting and supporting basic, clinical and translational medical
research, and it investigates the causes, treatments, and cures for both
common and rare diseases. For more information about NIH and its programs,
visit <www.nih.gov>.
###
This NIH News Release is available online at:
<http://www.nih.gov/news/pr/jan2007/nida-25a.htm>.
To subscribe (or unsubscribe) from this list, go to
http://list.nih.gov/cgi-bin/wa?SUBED1=nihpress&A=1.
------ End of Forwarded Message
|
